Strategic Outlooks

CMA’s Perspective

What we learn across deals and industries informs the decisions our clients make. Each of our articles offers insight into the market perspectives that only come from experience.
In this first part of a two-part series on the specialty chemicals industry, Ben Godbout, Managing Director and Head of Strategic and Transaction Advisory at CMA, looks at structural shifts that have put the sector under pressure.
Mergers & Acquisitions
Why Legacy Matters: Navigating Family Business Exits
CMA Announces Promotion of Stephen Funnell to Director
2026 CMA Outlook: What Our Managing Partners are Watching
Acquisitions Financing
2025 CMA M&A Roundtable: An Outlook on 2026
Carl Marks Advisors is now CMA. This rebrand is not a cosmetic change, but a reflection of how we operate today. Along with the new name, we refreshed our visual identity and redesigned the website. The result is a clearer, more intuitive platform. You’ll find the right experience, right team, and right context quickly.
Carl Marks Advisors Rebrands to CMA and Unveils Refreshed Website Reflecting New Identity
Healthcare
Financial Advisory
What It Takes to Lead an Organization Through a Natural Disaster
Consumer & Retail ProductsHealthcare
Inside the 2025 CMA Restructuring Roundtable
Carl Marks Advisors Announces the Addition of Vice President Nick Baro
Mergers & Acquisitions
Carl Marks Advisors Guides HealthTronics Through Recapitalization & New Investment Partnership
Culture, talent, and leadership call the plays that can turn AI’s potential into a champion. Let’s dive into the human grit that makes specialty manufacturing a winner.